- 2025 Year-End: €0.68-0.75 → HOLD
The stock should benefit from completed acquisitions and healthcare sector stabilization, though regulatory uncertainties may limit upside. - 2026 Forecast: €0.80-0.95 → BUY
Expected regulatory approvals and integration benefits from recent acquisitions should drive growth. - 2028 Projection: €1.20-1.50 → STRONG BUY
Full integration of healthcare services and potential market expansion could significantly increase valuation. - 2030 Vision: €1.80-2.50 → LONG-TERM HOLD
Demographic trends favoring healthcare services and potential international expansion create substantial upside potential.
How to Buy Morefield Group N.V. (MORE) Shares - Investment in Morefield Group N.V. (MORE) Stock
Thinking about adding healthcare innovation to your portfolio? Morefield Group N.V. offers a unique opportunity in the specialized medical device sector. This Dutch company combines steady healthcare demand with growth potential through strategic acquisitions. Let's explore why this stock deserves your attention and how you can make it part of your investment journey.
Article navigation
- 📈 Current Stock Performance and Market Position
- 🎯 Strategic Acquisition: Naviva Kraamzorg Deal
- 📊 6-Month Price Performance Analysis
- 🔮 Price Forecast: 2025-2030 Outlook
- ⚠️ Investment Risks to Consider
- ✅ Positive Signals for 2025
- 🛡️ What Should a Beginner Trader Do Today?
- ✅ How to Buy Morefield Group N.V. (MORE) Shares – Step by Step
- 💡 Why Pocket Option Appeals to New Investors
- 🌍 Company Overview: Morefield Group N.V. in 2025
📈 Current Stock Performance and Market Position
As of September 1, 2025, Morefield Group N.V. (MORE) trades at €0.63 on Euronext Amsterdam. The company has shown resilience in a challenging healthcare market, maintaining operations despite sector-wide headwinds.
Critical Date Alert: Mark your calendar for March 2026 when Morefield Group is expected to release its next earnings report. Historically, healthcare stocks experience significant price movements around earnings announcements, particularly when companies are navigating regulatory changes and market transitions.
Recent Price Volatility Patterns
The stock has demonstrated notable volatility over the past six months, with prices fluctuating between €0.57 and €0.745 based on available trading data. This range represents approximately 30% price variability, indicating both opportunity and risk for traders.
The most significant trading activity occurred in late June 2025, when the stock saw volumes exceeding 20,000 shares on strong performance days, suggesting institutional interest during periods of positive momentum.
🎯 Strategic Acquisition: Naviva Kraamzorg Deal
Morefield Group made waves in January 2025 with its agreement to acquire a minority stake in Naviva Kraamzorg B.V., one of the Netherlands’ largest maternity care providers. This strategic move demonstrates the company’s commitment to expanding its healthcare portfolio beyond medical devices into direct care services.
Deal Significance: Naviva serves approximately 20,000 families annually with over 1,300 maternity care professionals. The acquisition, subject to Dutch regulatory approvals from the Healthcare Authority (NZa) and Consumer & Markets Authority (ACM), represents Morefield’s diversification into high-demand healthcare services.
Investment company Value8, a major Morefield shareholder, provided partial financing for this transaction, showing confidence in the strategic direction. The deal was expected to close in Q1 2025, though regulatory timelines can extend beyond initial projections.
📊 6-Month Price Performance Analysis
| Period | Price Range | Key Drivers |
|---|---|---|
| March 2025 | €0.60-0.65 | Post-acquisition announcement stability |
| April 2025 | €0.58-0.62 | Healthcare sector regulatory concerns |
| May 2025 | €0.59-0.64 | Gradual recovery from sector pressures |
| June 2025 | €0.65-0.70 | Increased trading volume and momentum |
| July 2025 | €0.61-0.66 | Summer trading lull and consolidation |
| August 2025 | €0.70-0.71 | Stable trading with moderate volumes |
The overall trend shows resilience despite healthcare sector headwinds, with the stock maintaining most of its value while demonstrating occasional volatility spikes.
🔮 Price Forecast: 2025-2030 Outlook
Based on current market conditions and the company’s strategic positioning:
⚠️ Investment Risks to Consider
Market and Sector Risks
- Regulatory Uncertainty: Dutch healthcare regulations are undergoing changes that could impact reimbursement structures
- Sector Volatility: Healthcare stocks have underperformed the broader market, down 5% YTD versus market gains of 7%
- Political Pressures: Potential Medicaid cuts and pharmaceutical pricing reforms create sector-wide headwinds
Company-Specific Risks
- Execution Risk: Successful integration of Naviva Kraamzorg acquisition is critical
- Limited Analyst Coverage: As a smaller company, less research coverage means fewer market catalysts
- Currency Exposure: Headquarters in Curaçao while operating primarily in Eurozone creates currency risk
✅ Positive Signals for 2025
Growth Catalysts
- Strategic Diversification: Expansion into maternity care services provides new revenue streams
- Demographic Tailwinds: Aging population and healthcare demand growth support long-term fundamentals
- Value8 Support: Major shareholder involvement provides financial stability and strategic guidance
- Defensive Characteristics: Low beta of 0.62 offers relative stability during market turbulence
Sector Opportunities
- Healthcare Innovation: 77% of healthcare executives prioritizing AI adoption creates modernization opportunities
- Attractive Valuations: Healthcare sector trading at forward P/E of 16.2 versus market’s 22 presents value opportunity
- Long-term Demand: 65+ population expected to grow 41% by 2050 ensures sustained market need
🛡️ What Should a Beginner Trader Do Today?
Strategic Recommendations:
- Start Small: Begin with a position representing no more than 2-3% of your portfolio
- Dollar-Cost Average: Invest fixed amounts monthly to reduce timing risk
- Set Price Alerts: Monitor around €0.60 for potential entry points
- Patience Pays: Healthcare investments often require longer time horizons
Humorous Insight: “Trading MORE stock is like healthcare itself – sometimes you need to endure short-term discomfort for long-term wellness. Just don’t try to perform surgery on your portfolio every day!”
✅ How to Buy Morefield Group N.V. (MORE) Shares – Step by Step
| Step | Action | Why It Matters |
|---|---|---|
| 1 | Choose a Trading Platform | Ensure it offers access to Euronext Amsterdam exchange |
| 2 | Complete Account Verification | Provide required identification documents for compliance |
| 3 | Fund Your Account | Transfer sufficient capital for your intended investment |
| 4 | Search for “MORE” | Use the exact ticker symbol, not just company name |
| 5 | Select Order Type | Use limit orders to control entry price rather than market orders |
| 6 | Review Order Details | Double-check quantity, price, and total cost before confirming |
| 7 | Execute Purchase | Monitor order fulfillment and confirm position in your portfolio |
| 8 | Set Monitoring Alerts | Establish price alerts for your target exit points |
💡 Why Pocket Option Appeals to New Investors
For those considering Morefield Group N.V. investment, Pocket Option offers several advantages that align well with beginner needs:
Accessibility Features
- Minimum Deposit: Only $5 required to start trading, making it accessible for all investment levels
- Rapid Verification: KYC process completed with just one document, typically within minutes
- Withdrawal Options: Over 100 methods available including cryptocurrencies, e-wallets, and traditional banking
Educational Support:
The Pocket Option blog provides ongoing market analysis and educational content to help investors make informed decisions about stocks like Morefield Group N.V.
🌍 Company Overview: Morefield Group N.V. in 2025
Morefield Group operates as a specialized healthcare services company focused on assistive medical devices and disability aids. Founded in 1983 and headquartered in Willemstad, Curaçao, the company serves Dutch municipalities, healthcare offices, insurers, institutions, and private individuals.
The company’s business model includes selecting, advising, supplying, and maintaining aids for people with physical disabilities, plus sales and rental services for medical devices. With approximately 555 employees, Morefield maintains a focused presence in the specialized healthcare equipment sector.
Interesting Fact: In a unique corporate culture initiative, Morefield’s Curaçao headquarters features dedicated meditation rooms where employees can take stress-reduction breaks throughout the workday – perhaps the perfect environment for navigating healthcare market volatility!
FAQ
What is Morefield Group N.V.'s primary business?
The company specializes in assistive medical devices and disability aids, providing selection advice, sales, rental, and maintenance services primarily to Dutch healthcare clients.
How often does Morefield Group report earnings?
The company typically reports financial results semi-annually, with the next expected earnings announcement around March 2026.
What makes Morefield Group different from other healthcare stocks?
Its focus on specialized medical devices combined with recent expansion into direct care services through acquisitions creates a unique hybrid healthcare business model.
Is Morefield Group affected by U.S. healthcare policies?
While primarily operating in the Netherlands, global healthcare sector sentiment and regulatory trends can indirectly affect all healthcare companies.
What is the minimum investment required for MORE stock?
There's no set minimum, but investors should consider transaction costs relative to their investment size. Many platforms allow fractional share purchasing for smaller investments.
Signals
Sign up for more like this
Customize your newsfeed with content you're actually interested in — get up-to-date personalized newsletter in your inbox.
Your comment
Comments are pre-moderated to ensure they comply with our blog guidelines.